Gride 1mg Tablet contains Glimepiride, a sulfonylurea class oral hypoglycemic agent used in the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with inadequate response to diet and exercise alone. Gride 1mg is indicated for adults with type 2 diabetes who require additional glucose lowering when lifestyle modifications are insufficient. The medication is typically initiated at a low dose to minimize the risk of hypoglycemia and titrated based on glycemic response and tolerability. Glimepiride has a prolonged duration of action, allowing once-daily dosing, which may enhance patient compliance. It is important to monitor blood glucose levels regularly to avoid hypoglycemia, especially in elderly patients or those with renal or hepatic impairment. Gride 1mg should be used cautiously in combination with other antidiabetic agents to prevent additive hypoglycemic effects. Common adverse effects include hypoglycemia, weight gain, and gastrointestinal disturbances. Patients should be advised to maintain consistent dietary habits and promptly report symptoms of low blood sugar. Gride 1mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Regular follow-up and laboratory monitoring are essential to ensure optimal therapeutic outcomes.

Dosage & How to Use